Profile of oritavancin and its potential in the treatment of acute bacterial skin structure infections

Oritavancin, a semisynthetic derivative of the glycopeptide antibiotic chloroeremomycin, received the US Food and Drug Administration approval for the treatment of acute bacterial skin and skin structure infections caused by susceptible Gram-positive bacteria in adults in August 2014. This novel sec...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Infect Drug Resist
Egile Nagusiak: Mitra, Subhashis, Saeed, Usman, Havlichek, Daniel H, Stein, Gary E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Dove Medical Press 2015
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4500617/
https://ncbi.nlm.nih.gov/pubmed/26185459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IDR.S69412
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak